Royalty Pharma Plc (RPRX)
49.65
-1.07
(-2.11%)
USD |
NASDAQ |
May 07, 13:22
Royalty Pharma SG&A Expense (TTM) : 462.50M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Zymeworks, Inc. | 61.51M |
| Johnson & Johnson | 24.60B |
| Revolution Medicines, Inc. | 195.04M |
| Corcept Therapeutics, Inc. | 503.42M |
| Cytokinetics, Inc. | 226.90M |